tiprankstipranks
Trending News
More News >
Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ:AMLX
US Market

Amylyx Pharmaceuticals Inc (AMLX) Income Statement

Compare
653 Followers

Amylyx Pharmaceuticals Inc Income Statement

Last quarter (Q4 2025), Amylyx Pharmaceuticals Inc's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Amylyx Pharmaceuticals Inc's net income was $-33.00M. See Amylyx Pharmaceuticals Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 87.37M$ 380.79M$ 22.23M$ 0.00
Gross Profit
$ -525.00K$ 45.22M$ 355.35M$ 19.24M$ 0.00
Operating Expenses
$ 152.77M$ 359.95M$ 316.54M$ 220.58M$ 82.69M
Depreciation and Amortization
$ 525.00K$ 904.00K$ 1.09M$ 487.00K$ 52.00K
EBITDA
$ -144.16M$ -290.98M$ 39.89M$ -200.85M$ -82.64M
Operating Income
$ -153.29M$ -314.73M$ 38.80M$ -201.34M$ -82.69M
Other Income/Expenses
$ 8.60M$ 12.60M$ 15.49M$ 3.74M$ -5.24M
Pretax Income
$ -144.69M$ -302.14M$ 54.30M$ -197.60M$ -87.93M
Net Income
$ -144.74M$ -301.74M$ 49.27M$ -198.38M$ -87.93M
Per Share Metrics
Basic EPS
$ -1.53$ -4.43$ 0.73$ -2.98$ -1.52
Diluted EPS
$ -1.53$ -4.43$ 0.70$ -2.98$ -1.52
Weighted Average Shares Outstanding
94.57M 68.14M 67.23M 66.51M 57.86M
Weighted Average Shares Outstanding (Diluted)
94.57M 68.14M 69.99M 66.51M 57.86M
Currency in USD

Amylyx Pharmaceuticals Inc Earnings and Revenue History